Partner at King & Spalding
John Shakow is a Partner, King & Spalding. John’s practice focuses on complex regulatory, commercial and litigation issues related to all aspects of drug pricing and price reporting. He counsels pharmaceutical and biotechnology clients on their rights and obligations under the Medicaid, Medicare, Federal Supply Schedule, 340B and TRICARE programs. He has extensive experience helping clients resolve commercial, strategic, organizational and other legal challenges while maintaining the integrity of their price reporting compliance efforts.